Cargando…
Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer
Matrix metalloproteinase 9 (MMP9) and microRNA-145 (miR-145) have emerged as essential biomarkers in thyroid cancer progression and metastasis. However, their combined evaluation and clinical utility as a unified prognostic marker across diverse thyroid cancer subgroups remain unexplored. We investi...
Autores principales: | Toraih, Eman A., Hussein, Mohamed H., Al Ageeli, Essam, Ellaban, Mohamad, Kattan, Shahd W., Moroz, Krzysztof, Fawzy, Manal S., Kandil, Emad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669161/ https://www.ncbi.nlm.nih.gov/pubmed/38001954 http://dx.doi.org/10.3390/biomedicines11112953 |
Ejemplares similares
-
A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer
por: Toraih, Eman A., et al.
Publicado: (2022) -
Migration/Differentiation-Associated LncRNA SENCR rs12420823*C/T: A Novel Gene Variant Can Predict Survival and Recurrence in Patients with Breast Cancer
por: Ageeli, Essam Al, et al.
Publicado: (2022) -
MicroRNA-499a (rs3746444A/G) gene variant and susceptibility to type 2 diabetes-associated end-stage renal disease
por: Fawzy, Manal S., et al.
Publicado: (2022) -
Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma
por: Toraih, Eman A., et al.
Publicado: (2017) -
Long Non-Coding RNAs Gene Variants as Molecular Markers for Diabetic Retinopathy Risk and Response to Anti-VEGF Therapy
por: Mohammad, Hala M F, et al.
Publicado: (2021)